VIMTA LABS
Back to Cashflow Statement
|
VIMTA LABS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-17 Cr | ₹20 Cr | ₹4.61 Cr | ₹0.69 Cr | ₹2.84 Cr |
What is the latest Net Cash Inflow / Outflow ratio of VIMTA LABS ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-17 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹4.61 Cr |
Mar2021 | ₹0.69 Cr |
Mar2020 | ₹2.84 Cr |
How is Net Cash Inflow / Outflow of VIMTA LABS Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-17 Cr | Negative | |
Mar2023 | ₹20 Cr | 327.61 | |
Mar2022 | ₹4.61 Cr | 569.62 | |
Mar2021 | ₹0.69 Cr | -75.76 | |
Mar2020 | ₹2.84 Cr | - |
Compare Net Cash Inflow / Outflow of peers of VIMTA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VIMTA LABS | ₹2,158.3 Cr | 14.1% | -4.6% | 105.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 6% | 4% | 9.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 4.7% | 0.3% | 52.4% | Stock Analytics | |
CIPLA | ₹122,394.0 Cr | 7% | 3.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | 4.1% | 6.4% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 6.3% | 5% | -4.7% | Stock Analytics |
VIMTA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VIMTA LABS | 14.1% |
-4.6% |
105.1% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses